Skip to content

IAS: Studies present reassuring data on the use of ART in patients on TB treatment

IAS: Botswanan study finds low concentrations of TB drugs common in HIV-positives, predict TB treatment failure

IAS: Randomised comparison concludes d4T more tolerable than AZT in triple nuke PEP regimen

IAS: Daily aciclovir doesn't reduce HIV risk in HSV-2-infected women - was poor adherence the reason?

IAS: PEP following sexual assault in Kenya and Thailand - more awareness and follow-up necessary

Kaletra tablet for children coming soon, says Abbott

IAS: Hope and excitement as conference officially opens

Maraviroc gets scientific thumbs up from European drugs body

Pfizer advises maraviroc dose increase if combined with etravirine